US Patent 9981922 KDM1A inhibitors for the treatment of disease
Patent 9981922 was granted and assigned to Imago BioSciences Inc on May, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 21 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+389 characters)
Article
Patent abstract
Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDM1A, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Amy E. Tapper0
Cassandra Celatka0
Hugh Y. Rienhoff, Jr.0
John M. McCall0
Michael Clare0
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09981922 KDM1A inhibitors for the treatment of disease US Patent 9981922 KDM1A inhibitors for the treatment of disease
Infobox
Patent Number
099819220
Patent Number
99819220
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099819220
Date of Patent
May 29, 2018
0Patent Application Number
150431210
Date Filed
February 12, 2016
0Patent Primary Examiner
Edits on 20 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09981922 KDM1A inhibitors for the treatment of disease
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09981922
Date of patent
May 29, 2018
Patent application number
15043121
Date Filed
February 12, 2016
Patent primary examiner
Find more entities like US Patent 9981922 KDM1A inhibitors for the treatment of disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.